MARKET

MBX

MBX

MBX Biosciences Inc
NASDAQ
57.54
+3.91
+7.29%
After Hours: 57.54 0 0.00% 19:30 09/28 EDT
OPEN
52.86
PREV CLOSE
53.63
HIGH
58.49
LOW
52.59
VOLUME
439.61K
TURNOVER
--
52 WEEK HIGH
72.64
52 WEEK LOW
12.94
MARKET CAP
2.77B
P/E (TTM)
-23.9212
1D
5D
1M
3M
1Y
5Y
1D
MBX Biosciences: I Should Never Have Downgraded To Hold (Rating Upgrade)
Seeking Alpha · 5d ago
Weekly Report: what happened at MBX last week (0914-0918)?
Weekly Report · 09/21 09:43
Weekly Report: what happened at MBX last week (0907-0911)?
Weekly Report · 09/14 09:45
Press Release: MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer
Dow Jones · 09/08 12:00
Weekly Report: what happened at MBX last week (0831-0904)?
Weekly Report · 09/07 09:42
MBX Biosciences (MBX) Is Down 7.5% After Starting Phase 3 oPTimize Trial – Has The Bull Case Changed?
Simply Wall St · 09/04 05:35
Weekly Report: what happened at MBX last week (0824-0828)?
Weekly Report · 08/31 09:46
Septerna: GPCR Programs May Be Experimental, But I'm Holding For The Long Term
Seeking Alpha · 08/28 22:00
More
About MBX
MBX Biosciences, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies based on its proprietary PEP platform, for the treatment of endocrine and metabolic disorders. It is advancing a pipeline of novel candidates for endocrine and metabolic disorders with clinically validated targets and proven endpoints for regulatory approval. Its pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism in Phase III development and an obesity portfolio that includes MBX 4291 in Phase I development and MBX 5765 and MBX 6180 in preclinical development, as well as additional discovery candidates. Its lead obesity product candidate, MBX 4291, is designed to be a long-acting and highly potent glucagon-like peptide 1 (GLP-1) / glucose-dependent insulinotropic polypeptide (GIP) co-agonist prodrug with the goal of potential once-monthly dosing frequency.

Webull offers MBX Biosciences, Inc. stock information, including NASDAQ: MBX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MBX stock methods without spending real money on the virtual paper trading platform.